Michael Gold to Cost-Benefit Analysis
This is a "connection" page, showing publications Michael Gold has written about Cost-Benefit Analysis.
Connection Strength
0.818
-
Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998 Jun; 36(6):778-92.
Score: 0.128
-
Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine. J Gen Intern Med. 1997 Sep; 12(9):551-8.
Score: 0.121
-
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics. 1997 Feb; 11(2):159-68.
Score: 0.117
-
Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
Score: 0.116
-
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 23-30; 276(16):1339-41.
Score: 0.114
-
Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy. Heart Fail Clin. 2011 Apr; 7(2):241-50, ix.
Score: 0.078
-
Toward a broader view of values in cost-effectiveness analysis of health. Hastings Cent Rep. 1999 May-Jun; 29(3):7-15.
Score: 0.034
-
Assessing outcomes in population health: moving the field forward. Am J Prev Med. 1997 Jan-Feb; 13(1):3-5.
Score: 0.029
-
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16; 276(15):1253-8.
Score: 0.029
-
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 09; 276(14):1172-7.
Score: 0.029
-
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J. 2007 Jun; 153(6):951-9.
Score: 0.015
-
Improving value measurement in cost-effectiveness analysis. Med Care. 2000 Sep; 38(9):892-901.
Score: 0.009